Post-treatment Care of Breast Cancer Survivors

The proposed investigation is a randomized prospective evaluation of a Survivorship Intervention in improving the quality of care, treatment satisfaction and understanding of care in Latina and Caucasian breast cancer survivors treated in an urban academic medical center. Patients will be recruited within 6 weeks of completing their last definitive breast cancer therapy (radiation or chemotherapy). Patients will complete self administered baseline and follow-up questionnaires. Following baseline evaluation patients will be randomized to receiving either written information for follow-up care of cancer survivors published by the National Cancer Institute (Facing Forward), or the Survivorship Intervention. Patients will not be aware that they are participating in a randomized intervention. After verbally agreeing to participate they will be randomized to group A or B and will receive the corresponding consent. Patients will be re-assessed 3 and 6 months after enrollment.

Inclusion criteria

• Participants will be screened for the following inclusion criteria:
• Age >18 years
• History of stage 0, I, II, or IIIa breast cancer and no evidence of recurrent disease
• Within 6 weeks of completion of breast cancer therapy (Surgery, Radiation or Chemotherapy)
• Caucasian and/or Hispanic (English or Spanish-speaking)
• Willing to undergo a 1 hr cancer survivorship evaluation

Exclusion criteria

• Patients with the following active conditions or behaviors will be excluded from participation:
• Evidence of recurrent or metastatic breast cancer
• Patients who have received surgery only with no adjuvant therapy
• Uncontrolled or significant psychiatric illness/social situations that would preclude completion of questionnaire or follow-up evaluation.